Literature DB >> 33389631

An Overview on the Complexity of OCT4: at the Level of DNA, RNA and Protein.

Majid Mehravar1, Fatemeh Ghaemimanesh2, Ensieh M Poursani3.   

Abstract

OCT4 plays critical roles in self-renewal and pluripotency maintenance of embryonic stem cells, and is considered as one of the main stemness markers. It also has pivotal roles in early stages of embryonic development. Most studies on OCT4 have focused on the expression and function of OCT4A, which is the biggest isoform of OCT4 known so far. Recently, many studies have shown that OCT4 has various transcript variants, protein isoforms, as well as pseudogenes. Distinguishing the expression and function of these variants and isoforms is a big challenge in expression profiling studies of OCT4. Understanding how OCT4 is functioning in different contexts, depends on knowing of where and when each of OCT4 transcripts, isoforms and pseudogenes are expressed. Here, we review OCT4 known transcripts, isoforms and pseudogenes, as well as its interactions with other proteins, and emphasize the importance of discriminating each of them in order to understand the exact function of OCT4 in stem cells, normal development and development of diseases.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  Alternative promoter; Alternative splicing; Embryonic stem cell; Isoforms; OCT4; Pseudogenes; Stemness marker; Transcription factor; Variants

Mesh:

Substances:

Year:  2021        PMID: 33389631     DOI: 10.1007/s12015-020-10098-3

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   6.692


  79 in total

Review 1.  The transcriptional foundation of pluripotency.

Authors:  Ian Chambers; Simon R Tomlinson
Journal:  Development       Date:  2009-07       Impact factor: 6.868

2.  Oct4 and its pseudogenes confuse stem cell research.

Authors:  Stefanie Liedtke; Jürgen Enczmann; Simon Waclawczyk; Peter Wernet; Gesine Kögler
Journal:  Cell Stem Cell       Date:  2007-10-11       Impact factor: 24.633

3.  Regulation of Oct-4 gene expression during differentiation of EC cells.

Authors:  J Schoorlemmer; L Jonk; S Sanbing; A van Puijenbroek; A Feijen; W Kruijer
Journal:  Mol Biol Rep       Date:  1995       Impact factor: 2.316

4.  Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4.

Authors:  J Nichols; B Zevnik; K Anastassiadis; H Niwa; D Klewe-Nebenius; I Chambers; H Schöler; A Smith
Journal:  Cell       Date:  1998-10-30       Impact factor: 41.582

5.  Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker.

Authors:  Stefano Zangrossi; Mirko Marabese; Massimo Broggini; Rosaria Giordano; Marco D'Erasmo; Elisa Montelatici; Daniela Intini; Antonino Neri; Maurizio Pesce; Paolo Rebulla; Lorenza Lazzari
Journal:  Stem Cells       Date:  2007-03-22       Impact factor: 6.277

Review 6.  From adult stem cells to cancer stem cells: Oct-4 Gene, cell-cell communication, and hormones during tumor promotion.

Authors:  James E Trosko
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

Review 7.  Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology.

Authors:  Xia Wang; Jianwu Dai
Journal:  Stem Cells       Date:  2010-05       Impact factor: 6.277

Review 8.  Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research.

Authors:  Stefanie Liedtke; Milaid Stephan; Gesine Kögler
Journal:  Biol Chem       Date:  2008-07       Impact factor: 3.915

9.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

10.  Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells.

Authors:  Maryam M Matin; James R Walsh; Paul J Gokhale; Jonathan S Draper; Ahmad R Bahrami; Ian Morton; Harry D Moore; Peter W Andrews
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

View more
  5 in total

Review 1.  Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies.

Authors:  Yue Zheng; Laduona Wang; Limei Yin; Zhuoran Yao; Ruizhan Tong; Jianxin Xue; You Lu
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

2.  Generation of biologically active recombinant human OCT4 protein from E. coli.

Authors:  Chandrima Dey; Madhuri Thool; Srirupa Bhattacharyya; S Sudhagar; Rajkumar P Thummer
Journal:  3 Biotech       Date:  2021-04-08       Impact factor: 2.406

3.  Exon and intron sharing in opposite direction-an undocumented phenomenon in human genome-between Pou5f1 and Tcf19 genes.

Authors:  Majid Mehravar; Fatemeh Ghaemimanesh; Ensieh M Poursani
Journal:  BMC Genomics       Date:  2021-10-05       Impact factor: 3.969

4.  HPV16 E6-Activated OCT4 Promotes Cervical Cancer Progression by Suppressing p53 Expression via Co-Repressor NCOR1.

Authors:  Shujuan Shu; Zhi Li; Liu Liu; Xia Ying; Yina Zhang; Ting Wang; Xiaoye Zhou; Peiyue Jiang; Weiguo Lv
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

5.  Endometrial Cancer-Adjacent Tissues Express Higher Levels of Cancer-Promoting Genes than the Matched Tumors.

Authors:  Mariusz Kulinczak; Maria Sromek; Grzegorz Panek; Klara Zakrzewska; Renata Lotocka; Lukasz Michal Szafron; Magdalena Chechlinska; Jan Konrad Siwicki
Journal:  Genes (Basel)       Date:  2022-09-08       Impact factor: 4.141

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.